NIH issues details for CNS program
This program is open to domestic government laboratories, companies and academic institutions in order to conduct efficacy data to support research proposals submitted to CounterACT or other peer-reviewed grant programs. The notice states that this participation does not replace requirements to collaborate with laboratory facilities that are authorized to work with restricted chemical agents.
As a part of the program, researchers will have access to established screening models involving animal subjects. These would be used to test the efficacy of proposed compounds against organophosphorus chemicals and those that pose a threat to the nervous system.
Those that are accepted by the CNS will not incur costs associated with the supported studies. They note that studies should not overlap with others that are within another CounterACT grant program, but they may be performed together under this program.
Those interested in the program should contact CounterACT Program Project Manager Dave Yeung at email@example.com. For application purposes, suppliers and investigators will need to provide information relating to the candidate's solubility, toxicity, purity and previous efficacy study data if available.